Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.

Documenti analoghi

• Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy.
  di: Holodniy, M, et al.
  Pubblicazione: (1995)
• Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.
  di: Frenkel, L M, et al.
  Pubblicazione: (1995)
• Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assay.
  di: McLeod, G X, et al.
  Pubblicazione: (1992)
• Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy
  di: Eastman, P. Scott, et al.
  Pubblicazione: (1998)
• Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay.
  di: Larder, B A, et al.
  Pubblicazione: (1990)